Literature DB >> 21576275

Idiopathic thrombocytopenic purpura and coronary artery disease: comparison between coronary artery bypass grafting and percutaneous coronary intervention.

Antonio Russo1, Marina Cannizzo, Gabriele Ghetti, Elena Barbaresi, Elisa Filippini, Salvatore Specchia, Angelo Branzi.   

Abstract

Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by a low platelet count and an increased risk of bleeding. At the same time, ITP patients present an increased risk of thrombosis and atherosclerosis related to the high presence of haemostatic factors and chronic steroid therapy. Although relatively rare, the association of ITP and coronary artery disease represents a complex therapeutic challenge. In particular, no recommendations exist regarding the best management approach. We reviewed the literature making a comparison between coronary artery bypass grafting and percutaneous coronary intervention.

Entities:  

Mesh:

Year:  2011        PMID: 21576275     DOI: 10.1510/icvts.2011.271296

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  8 in total

Review 1.  Platelet transfusion in hematology, oncology and surgery.

Authors:  Hannes Wandt; Kerstin Schäfer-Eckart; Andreas Greinacher
Journal:  Dtsch Arztebl Int       Date:  2014-11-28       Impact factor: 5.594

2.  The presence of idiopathic thrombocytopenic purpura and incidence of acute non-ST elevation myocardial infarction.

Authors:  Mitchell Davis; Mohammad Reza Movahed; Mehrtash Hashemzadeh; Mehrnoosh Hashemzadeh
Journal:  Ann Hematol       Date:  2021-10-01       Impact factor: 3.673

3.  Recurrent Coronary Thrombus in a Patient with Chronic Immune Thrombocytopenia with Treatment Using Eltrombopag.

Authors:  Terumori Satoh; Masao Saotome; Kenichiro Suwa; Hayato Ohtani; Yasuyuki Nagata; Takaaki Ono; Yuichiro Maekawa
Journal:  Case Rep Cardiol       Date:  2019-03-26

4.  Revascularization for patients with idiopathic thrombocytopenic purpura and coronary artery disease.

Authors:  Chan-Hee Lee; Ung Kim
Journal:  Korean Circ J       Date:  2014-07-25       Impact factor: 3.243

Review 5.  Two cases and review of the literature: primary percutaneous angiography and antiplatelet management in patients with immune thrombocytopenic purpura.

Authors:  Estelle Torbey; Harout Yacoub; Donald McCord; James Lafferty
Journal:  ISRN Hematol       Date:  2013-12-29

6.  Coronary intervention for acute coronary syndrome in a 51-year-old man with immune thrombocytopenic purpura: a case report.

Authors:  Bora Demircelik; Meltem Altinsoy; Fadime Bozduman; Mahmut Gunes; Muzaffer Cakmak; Beyhan Eryonucu
Journal:  J Med Case Rep       Date:  2014-06-20

Review 7.  Recurrent acute coronary syndrome and restenosis after percutaneous coronary intervention in a patient with idiopathic thrombocytopenic purpura: a case report and literature review.

Authors:  Ge Li-Sha; Chen Peng; Li Yue-Chun
Journal:  BMC Cardiovasc Disord       Date:  2015-09-18       Impact factor: 2.298

8.  Impact of immune thrombocytopenic purpura on clinical outcomes in patients with acute myocardial infarction.

Authors:  Omar Chehab; Nadine Abdallah; Amjad Kanj; Mohit Pahuja; Oluwole Adegbala; Rami Z Morsi; Tushar Mishra; Luis Afonso; Aiden Abidov
Journal:  Clin Cardiol       Date:  2019-11-11       Impact factor: 2.882

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.